Reuters logo
3 个月前
BRIEF-Proteon Therapeutics qtrly net loss per share attributable to common stockholders $0.39
2017年5月10日 / 下午12点30分 / 3 个月前

BRIEF-Proteon Therapeutics qtrly net loss per share attributable to common stockholders $0.39

1 分钟阅读

May 10 (Reuters) - Proteon Therapeutics Inc:

* Proteon Therapeutics announces first quarter 2017 financial results

* Qtrly net loss per share attributable to common stockholders $0.39

* Proteon Therapeutics - expects its cash, cash equivalents and available-for-sale investments will be sufficient to fund its operations into Q3 of 2018. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below